PFS Group S.L. Revenue and Competitors
Estimated Revenue & Valuation
- PFS Group S.L.'s estimated annual revenue is currently $61.3M per year.
- PFS Group S.L.'s estimated revenue per employee is $181,250
Employee Data
- PFS Group S.L. has 338 Employees.
- PFS Group S.L. grew their employee count by 1% last year.
PFS Group S.L.'s People
Name | Title | Email/Phone |
---|
PFS Group S.L. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.1M | 132 | -7% | N/A | N/A |
#2 | $17.8M | 123 | 22% | N/A | N/A |
#3 | $19.6M | 135 | 25% | N/A | N/A |
#4 | $3.6M | 31 | -31% | N/A | N/A |
#5 | $4.2M | 36 | -18% | N/A | N/A |
#6 | $13.3M | 92 | -29% | N/A | N/A |
#7 | $16.2M | 112 | 6% | N/A | N/A |
#8 | $0.6M | 8 | -33% | N/A | N/A |
#9 | $5.7M | 49 | 29% | N/A | N/A |
#10 | $13.6M | 94 | 42% | N/A | N/A |
What Is PFS Group S.L.?
Nuestra trayectoria se inicia en 1999 y hoy somos una compañÃa especializada en el mercado español en materia de Riesgo de Crédito y Recuperaciones. Somos una empresa que orienta su actividad a la búsqueda de soluciones en la gestión del Riesgo de Crédito y Recuperaciones de las entidades financieras. Cada proyecto en el que participamos se distingue de los otros , ya que recibe un tratamiento único y es adaptado a las necesidades y circunstancias de nuestros clientes. Cuidar a las personas es uno de los objetivos de PFS Group, asà como retener el talento. Nuestras polÃticas y planes personalizados nos permiten atender las necesidades individuales y adaptarnos a las caracterÃsticas de todos.
keywords:N/AN/A
Total Funding
338
Number of Employees
$61.3M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PFS Group S.L. News
As shown in Table 3, the 5-year PFS and OS rates were likewise inferior in the PAR?4.9, CA 199 90 U/mL, and node-positive patients groups (...
Results from the MONALEESA-7 trial also show a significantly longer duration of PFS in the RIBO group than in the placebo group; the median...
Patients receiving transplant at their CR1 state had better PFS and OS. ... which the rituximab group had superior event-free survival, PFS,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $137.3M | 338 | 26% | N/A |
#2 | N/A | 342 | 6% | N/A |
#3 | $62.2M | 343 | -20% | N/A |
#4 | $64.5M | 344 | 9% | N/A |
#5 | $60.4M | 345 | 6% | N/A |